Search

everythinglearnresearchcommunity

for

Search:↓

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Nanocosmetics with natural extracts offer benefits but need more research on safety and environmental impact.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Functionalized hydrogels can help heal tissues and fight infections by delivering beneficial bacteria and antimicrobials.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Finasteride may affect male fertility by interfering with specific sperm signaling.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Ixekizumab has known and some unexpected side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.